Drug Research and Development: The COVID pandemic has driven rapid development of drugs and vaccines to combat the virus. Unprecedented efforts have been made to identify and test effective treatments, as well as to develop safe and effective vaccines in record time.

​

 

Redirection of Resources: The pandemic has led to a reorientation of research and development resources towards COVID-19, which has to some extent affected the progress of research and development of drugs for other diseases.

 

 

Shortages and Supply Chain: Demand for certain medications increased during the pandemic, leading to shortages and problems in the global supply chain. Some drugs experienced disruptions in production and distribution due to factory closures, transportation restrictions, and increased demand.

​

Telemedicine and Telepharmacy: The pandemic accelerated the adoption of telemedicine and telepharmacy as alternatives for medical care and medication dispensing. This has changed the way people access medicines and has driven the need for remote healthcare services and home delivery of medicines, where once again the pharmacist plays a vital role.

​

Changes in Prescribing Patterns: The pandemic has influenced drug prescribing patterns. For example, changes have been observed in the prescription of medications to treat conditions related to stress, anxiety and depression due to the psychological and emotional impact of the pandemic.

​

Accelerated Regulation and Approval: To address the public health emergency, accelerated review and approval processes have been implemented for COVID-19 related medications and vaccines. This has allowed for faster availability of treatments and vaccines to combat the disease.​

​

Technological Innovation: The pandemic has stimulated technological innovation in the pharmaceutical industry, including the use of artificial intelligence and big data analysis for drug research, as well as the adoption of new technologies in drug manufacturing and distribution.